Occudo Quantitative Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Occudo Quantitative Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,128	Closed	-$2.06M	–	840
2025 Q4	$2.06M	Buy	12,128 +7,236	+148%	+$1.11M	0.14%	207
2025 Q3	$645K	Sell	4,892 -1,130	-19%	-$136K	0.08%	342
2025 Q2	$639K	Sell	6,022 -10,056	-63%	-$1.09M	0.07%	320
2025 Q1	$1.98M	Buy	+16,078	New	+$2.1M	0.26%	102
2024 Q4	–	Sell	-3,599	Closed	-$401K	–	810
2024 Q3	$401K	Buy	+3,599	New	+$394K	0.07%	343
2022 Q1	–	Sell	-7,161	Closed	-$912K	–	1228
2021 Q4	$912K	Buy	+7,161	New	+$941K	0.08%	397
2021 Q3	–	Sell	-10,642	Closed	-$1.89M	–	1074
2021 Q2	$1.89M	Buy	10,642 +4,706	+79%	+$815K	0.29%	74
2021 Q1	$976K	Buy	5,936 +1,948	+49%	+$321K	0.21%	132
2020 Q4	$658K	Buy	+3,988	New	+$594K	0.21%	148

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Occudo Quantitative Strategies's JAZZ Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 12,128 shares — an estimated $2.06M sold.

Occudo Quantitative Strategies first reported a position in JAZZ in Q4 2020 and held it in 9 quarters. The position peaked at $2.06M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Occudo Quantitative Strategies reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 12,128 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.06M.
Occudo Quantitative Strategies first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 9 quarters.
Occudo Quantitative Strategies's Jazz Pharmaceuticals position peaked at $2.06M in Q4 2025.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.